Cardiovascular Manifestations and Mechanisms in Patients with COVID-19Opinion Published on 2020-10-162023-06-14 Journal: Trends in endocrinology and metabolism: TEM [Category] MERS, SARS, [키워드] ACE2 cardiovascular COVID-19 Cytokine storm endothelial cell damage Thromboinflammation Type 2 myocardial infarction [DOI] 10.1016/j.tem.2020.10.001 PMC 바로가기 [Article Type] Opinion
Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchangeCase Report Published on 2020-10-072022-11-01 Journal: Clinical Case Reports [Category] COVID-19, [키워드] COVID‐19 COVID‐19 Cytokine release syndrome neurological manifestation Peripheral Neuropathy plasma exchange resolved Safe syndrome Therapeutic plasma exchange therapy Thromboinflammation [DOI] 10.1002/ccr3.3397 PMC 바로가기 [Article Type] Case Report
Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19Medicine Published on 2020-08-252022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Admission anticoagulant (MeSH) Barcelona C-reactive protein collected data consecutive patient correlated COVID-19 CRP CRP level CTPA D-dimer D-dimer level Diagnosis dose Embolism exhibited Factor greater hospital Hospital stay hospitalized patient ICU in-hospital mortality incidence Increased increased risk independent Inpatients laboratory-confirmed low molecular weight mechanical ventilation Older PaO Patient patients without PE peak D-dimer Predictive Prevent pulmonary pulmonary angiography pulmonary embolism (MeSH) pulmonary thrombosis required Thromboinflammation Thromboprophylaxis university hospital was performed [DOI] 10.3389/fmed.2020.00557 PMC 바로가기 [Article Type] Medicine
Thromboembolic events and Covid-19Research article Published on 2020-08-012022-10-05 Journal: Advances in biological regulation [Category] SARS, 바이오마커, [키워드] Activation acute respiratory distress acute respiratory distress syndrome Anticoagulant treatment Anticoagulants anticoagulation Antithrombotic Biomarker China Coagulopathy condition Corona virus COVID-19 death event Frequency Healthcare systems Hemostasis Increased Infection Infectious disease knowledge Manifestations Mortality multiple organ failure pandemic parameters patients patients treated Platelet Platelets progressed Prolonged infection Respiratory failure responsible syndrome the SARS-CoV-2 virus thromboembolic Thromboembolic event Thromboembolic events Thromboinflammation tissue lesion [DOI] 10.1016/j.jbior.2020.100735 [Article Type] Research article
Extrapulmonary manifestations of COVID-19 Reviews Published on 2020-07-102022-10-05 Journal: Nature Medicine [Category] SARS, 바이오마커, 유전자 메커니즘, 임상, 치료제, [키워드] ACE2 acute coronary syndromes Acute kidney injury addition arrhythmia clinician complications condition contribute coronavirus SARS-CoV-2 COVID-19 dysregulation endothelial damage entry receptor expressed Extrapulmonary extrapulmonary tissues gastrointestinal symptoms hepatocellular injury hyperglycemia illnesses immune responses include Injury involved management manifestation Manifestations mechanism Myocardial dysfunction neurologic ocular organ system organ-specific pathology pathophysiology pathway patients with COVID-19 recognizing Research Symptoms therapeutic strategy Thromboinflammation Thrombotic complications tissue damage [DOI] 10.1038/s41591-020-0968-3 [Article Type] Reviews